Check out your Company Bowl for anonymous work chats.
The most dangerous thing about health advice from AI isn't that it can be wrong. It's that it's generally delivered like it's right -- confident, step-by-step, empathetic, tuned to how you like to read. Without the proper training and experience, it can be impossible for someone to recognize when or if the AI reasoning has gone sideways. Verily Health is focused on building AI models and agents that are trained and validated for accuracy, with individual agents tuned to specific steps in care process. Verily Me has a multi-agent system in action that can prioritize health context, state limitations, and maintain human pathways for critical moments. A confident tone is not a substitute for accuracy. Read why building confidence in healthcare AI requires ongoing investment and collaboration.
When AI sounds right, but isn't: how to better train your AI for clinical care | Verily | Precision Health Company
⚽ As millions of fans gather for the 2026 world soccer games, protecting public health remains a top priority. Verily Health is collaborating with Samsung Electronics America as part of the Health Security Operations Center (HSOC) to support this effort. By combining our wastewater monitoring solution, Sightline, and our research environment, Workbench, with Samsung’s hardware, we are helping to monitor for infectious disease threats across 16 sites. Earlier this year we announced our work with Samsung to integrate Galaxy Watch 8 with our precision health platform, Pre. Together we are accelerating research for life sciences and government customers by combining advanced health analytics with consumer-grade wearable data.
Samsung Technology Powers the Health Security Operations Center Monitoring for Infectious Disease Risks During 2026 World Soccer Games
A new study in npj Parkinson's Disease journal finds that digital measures of walking and non-walking behaviors, captured by a smartwatch, can track the progression of early to mid-stage Parkinson’s disease (PD). The study, led by Verily Health with co-authors from Radboud University Medical Center, Duke University School of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, and University of Pennsylvania School of Medicine, is the first to show change in in-real life mobility and sedentary behaviors over 1–2 years of early to mid-stage PD, using the Parkinson's Precision Medicine Initiative, Personalized Parkinson Project, and Project Baseline Health Study datasets. These digital measures showed significant and sustained changes within as few as 10 months, providing early indication of disease progression with greater sensitivity than current clinical measures. This insight could lead to more efficient clinical trial design and earlier, more proactive disease management strategies for people with PD. To accelerate further research, a subset of data and measures from the datasets will be made publicly available to researchers on Verily’s precision health platform, Pre.
Client Challenge
⚽ As we gear up for the USA soccer match against Bosnia and Herzegovina, we’re checking the public health score in the San Francisco Bay Area where the game will be played. Here are the latest pathogen trends from our wastewater monitoring dashboard: • Not detected: Measles • Low: Influenza A, Norovirus GII, RSV • Very low: SARS-CoV-2 As always, washing hands can reduce the spread of viruses, so let’s keep it clean as we cheer on Team USA!
Pathogen monitoring for the world soccer tournament cities 2026 | Verily Sightline
Biomedical research is often bottlenecked by the technical complexity of analyzing multi-layered hierarchical data, creating a "persona gap" between clinical experts and data scientists. Discover how Verily Data Explorer, built on clinical expertise from Vanderbilt University Medical Center can bridge the divide between clinical and technical expertise.
https://lp.verily.com/rs/541-ENE-620/images/Verily-VUMC_Data-Explorer_Whitepaper.pdf
We are excited to join Fast Company and The Johns Hopkins University for an evening of conversation on applied health: where technology meets the body. In a fireside chat, our CEO Stephen Gillett and Brendan Vaughan will explore the next era of precision health – making healthcare more predictive, preventive and precise. 🗓️ Tuesday, June 30 at 7:00 PM ET 📍 Washington, D.C.
World Changing Ideas: Conversations
“This World Cup is a step forward—we have people coming from around the world, and the disease environment could change relatively quickly. We need a signal today, and not six weeks from today,” says Dr. Vindell Washington, Verily Health Chief Physician Executive. As the 2026 world soccer games continue, our wastewater monitoring efforts to safeguard public health are in full gear. Our dashboard is providing continuous updates on pathogen trends (SARS-CoV-2, RSV, Influenza A) across 16 North American sites.
The World Cup Is Bringing Millions to the U.S. Here's What Experts Say About Infectious-Disease Risk
What if the patient, not just the molecule, were the true driver of medical innovation? 💡 Dr. Vindell Washington, Verily Health Chief Physician Executive, will take the stage at Aspen Ideas: Health for an insightful discussion on how patient data is reshaping the future of medicine. The panel will explore how integrating clinical, real-world, and patient-reported data across the entire care journey is fueling earlier diagnoses, smarter care pathways, and a new era of medical breakthroughs.
The Data is the Drug: How Patients Are Rewriting the Rules of Medical Innovation | Aspen Ideas
Carolyn Bradner Jasik, MD, Verily Health Associate Chief Clinical Officer, kicked off AHIP 2026 this week with a deep dive into a new category of AI-enabled care. Key insights: ➡️ “The technology is actually the easy part.” While AI development is manageable, the challenge is building an ecosystem of partnerships to handle regulation, payment, auditing, and ensuring physician support. ➡️ “You cannot do AI if you don't have clean data, a lot of data, and the right data.” Successful implementation of AI in healthcare is dependent on data quality. ➡️ "Patients just want good, accurate, helpful, empathetic care." Despite the complexity of models and protocols, the primary objective remains focused on the patient.
Carolyn Bradner Jasik, MD, Verily Health Associate Chief Clinical Officer, kicked off AHIP 2026 this week with a deep dive into a new category of AI-enabled care. Key insights: ➡️ “The technology is actually the easy part.” While AI development is manageable, the challenge is building an ecosystem of partnerships to handle regulation, payment, auditing, and ensuring physician support. ➡️ “You cannot do AI if you don't have clean data, a lot of data, and the right data.” Successful implementation of AI in healthcare is dependent on data quality. ➡️ "Patients just want good, accurate, helpful, empathetic care." Despite the complexity of models and protocols, the primary objective remains focused on the patient.
During the recent Bio-IT World Conference, David Glazer, Verily Distinguished Engineer, presented on "Solving for friction: Next-generation TREs for accelerating discovery." He highlighted three key barriers slowing biomedical discovery: • Policy friction (complex data use agreements) • Science friction (time spent on data wrangling) • Technology friction (fragmented tooling) Verily Pre, our AI-native platform for precision health, is designed to reduce this friction. It includes Refinery for data cleaning, Exchange for data discovery, and Workbench as an intuitive Trusted Research Environment (TRE) for secure analysis. During the conference, Jonathan Z Amar, Verily AI and Data Science Manager, joined a panel discussing data-specialized foundation models (FMs). He shared Verily’s approach to training a multi-modal foundation model on the All of Us (AOU) Research Program data, and how that might unblock new insights to predict disease risk and improve our understanding of health over time.
Next-generation Trusted Research Environments (TREs) for accelerating biomedical discovery